Immature platelet fraction predicts early marrow recovery after severe chemotherapy associated neutropenia

[1]  B. Akyıldız,et al.  Comparison of the value of immature retyculocyte and immature platelet in the diagnosıs of sepsis. , 2021, Pediatrics international : official journal of the Japan Pediatric Society.

[2]  S. Nair,et al.  Role of immature platelet fraction (IPF) in sepsis patients: A systematic review , 2021, Journal of family medicine and primary care.

[3]  N. Dempsey-Hibbert,et al.  Immature platelet indices alongside procalcitonin for sensitive and specific identification of bacteremia in the intensive care unit , 2020, Platelets.

[4]  H. Harmouche,et al.  Immature platelets: a review of the available evidence. , 2020, Thrombosis research.

[5]  W. Kamps,et al.  Risk-adapted approach for fever and neutropenia in paediatric cancer patients--a national multicentre study. , 2016, European journal of cancer.

[6]  A. Simon,et al.  Bloodstream infection in paediatric cancer centres—leukaemia and relapsed malignancies are independent risk factors , 2015, European Journal of Pediatrics.

[7]  H. Hasle,et al.  Absolute immature platelet count may predict imminent platelet recovery in thrombocytopenic children following chemotherapy , 2013, Pediatric blood & cancer.

[8]  M. Akova,et al.  Management of febrile neutropenia in the era of bacterial resistance , 2013, Therapeutic advances in infectious disease.

[9]  S. Kurtin.  Myeloid Toxicity of Cancer Treatment , 2012, Journal of the advanced practitioner in oncology.

[10]  E. Mohammadi,et al.  Barriers and facilitators related to the implementation of a physiological track and trigger system: A systematic review of the qualitative evidence , 2017, International journal for quality in health care : journal of the International Society for Quality in Health Care.

[11]  G. Gaedicke,et al.  Immature platelet count: A simple parameter for distinguishing thrombocytopenia in pediatric acute lymphocytic leukemia from immune thrombocytopenia , 2011, Pediatric blood & cancer.

[12]  K. Sepkowitz,et al.  Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 Update by the Infectious Diseases Society of America. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[13]  K. Sepkowitz,et al.  Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 Update by the Infectious Diseases Society of America. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[14]  P. Anderson.  Predicting and facilitating survival of pediatric cancer patients: The ALC story , 2010, Pediatric blood & cancer.

[15]  D. Eslin,et al.  Prognostic significance of early lymphocyte recovery in pediatric osteosarcoma , 2010, Pediatric blood & cancer.

[16]  Hee-Jin Kim,et al.  Immature platelet fraction: establishment of a reference interval and diagnostic measure for thrombocytopenia. , 2010, The Korean journal of laboratory medicine.

[17]  G. Schmalisch,et al.  Immature platelet fraction as novel laboratory parameter predicting the course of neonatal thrombocytopenia , 2009, British journal of haematology.

[18]  Y. Takeshima,et al.  Automatic detection of immature platelets for decision making regarding platelet transfusion indications for pediatric patients. , 2008, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.

[19]  H. Grier,et al.  Early lymphocyte recovery in Ewing sarcoma. , 2007, Journal of pediatric hematology/oncology.

[20]  S. Nakao,et al.  Immature platelet fraction for prediction of platelet engraftment after allogeneic stem cell transplantation , 2007, Bone Marrow Transplantation.

[21]  E. Kleinerman,et al.  Early Lymphocyte Recovery as a Prognostic Indicator for High-risk Ewing Sarcoma , 2007, Journal of pediatric hematology/oncology.

[22]  K. Reid,et al.  Immature platelet fraction as a predictor of platelet recovery following hematopoietic progenitor cell transplantation. , 2006, Laboratory hematology : official publication of the International Society for Laboratory Hematology.

[23]  D. Hart,et al.  Immature platelet fraction measurement: a future guide to platelet transfusion requirement after haematopoietic stem cell transplantation , 2006, Transfusion medicine.

[24]  Y. Abe,et al.  A simple technique to determine thrombopoiesis level using immature platelet fraction (IPF). , 2006, Thrombosis research.

[25]  K. Tamura.  Clinical guidelines for the management of neutropenic patients with unexplained fever in Japan: validation by the Japan Febrile Neutropenia Study Group. , 2005, International journal of antimicrobial agents.

[26]  N. Casadevall,et al.  Reticulated platelets: a reliable measure to reduce prophylactic platelet transfusions after intensive chemotherapy , 2005, Transfusion.

[27]  D. Hart,et al.  Assessment of an immature platelet fraction (IPF) in peripheral thrombocytopenia , 2004, British journal of haematology.

[28]  C. Dame.  Developmental biology of thrombopoietin in the human fetus and neonate , 2002, Acta paediatrica (Oslo, Norway : 1992). Supplement.

[29]  P. Noris,et al.  Relationship between size and thiazole orange fluorescence of platelets in patients undergoing high‐dose chemotherapy , 1999, British journal of haematology.

[30]  C. Begley,et al.  Administration of pegylated recombinant human megakaryocyte growth and development factor to humans stimulates the production of functional platelets that show no evidence of in vivo activation. , 1996, Blood.

[31]  E. M. Richards,et al.  Quantitation of reticulated platelets: methodology and clinical application , 1995, British journal of haematology.

[32]  B. Smith,et al.  Reticulated platelets in the evaluation of thrombopoietic disorders. , 1993, Archives of pathology & laboratory medicine.

[33]  R. Hillman,et al.  The significance of platelets with increased RNA content (reticulated platelets). A measure of the rate of thrombopoiesis. , 1992, American journal of clinical pathology.

[34]  G. Schmitz,et al.  Flow cytometric analysis of thiazole orange uptake by platelets: a diagnostic aid in the evaluation of thrombocytopenic disorders. , 1990, Blood.